Join
Live feed
·
PRReleasevia Quantisnow
Curis Inc. logo

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split

ByQuantisnow·Wall Street's wire, on your screen.
CRIS· Curis Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRIS (Curis Inc.) and more on Quantisnow.